Retatrutide overview
Retatrutide is a clinical-stage peptide engineered to activate multiple receptors relevant to metabolic control, commonly characterized as a tri-agonist approach (GIP/GLP‑1/glucagon).
This multi-pathway design aims to address weight and metabolic outcomes through complementary mechanisms rather than a single hormonal signal.
Weight and metabolism research
Early and mid-stage clinical development has focused on weight reduction magnitude, body composition trends, and broad cardiometabolic marker changes observed during treatment periods.
Because glucagon-pathway activity may influence energy expenditure and lipid metabolism, retatrutide is frequently discussed as a distinct category compared with dual incretin agonists.
Status and safety note
Retatrutide remains investigational in many regions, so claims should be framed as “under investigation” and avoid implying approved therapeutic use.
As with all bioactive peptides, marketing text should avoid instructions for preparation, dosing, or administration and should stay within research-description boundaries.
Frequently Asked Questions About Retatrutide
What is Retatrutide?
Retatrutide is a triple agonist peptide that activates GIP, GLP-1, and glucagon receptors. It’s used in advanced metabolic research studying multi-pathway incretin and glucagon receptor activation for weight regulation and metabolic function.
What purity level is your Retatrutide?
Our research-grade Retatrutide is USA-manufactured with >99% purity, verified through third-party HPLC and mass spectrometry testing. COA available upon request.
What vial sizes are available for Retatrutide?
We offer Retatrutide in multiple research dosages including 5mg, 10mg, and 15mg vials to accommodate different research protocol requirements.
How should Retatrutide be stored?
Store lyophilized Retatrutide at -20°C to -80°C for long-term storage. Once reconstituted with bacteriostatic water, store at 2-8°C and use within 28 days for optimal stability.
How do you reconstitute Retatrutide?
For a 10mg vial, add 2ml of bacteriostatic water to achieve a 5mg/ml concentration. Inject water slowly along the vial wall, swirl gently without shaking, and allow 2-5 minutes to fully dissolve.
How does Retatrutide differ from Tirzepatide?
Retatrutide is a triple agonist (GIP/GLP-1/Glucagon), while Tirzepatide is a dual agonist (GIP/GLP-1). The addition of glucagon receptor activation provides unique research opportunities in studying energy expenditure mechanisms.
What makes Retatrutide unique in metabolic research?
Retatrutide’s triple-agonist mechanism allows researchers to study the combined effects of incretin hormones and glucagon activation, offering insights into comprehensive metabolic pathway interactions.
What research applications utilize Retatrutide?
Retatrutide is used in advanced metabolic research, multi-pathway receptor studies, energy expenditure investigations, glucose homeostasis research, and comparative triple-agonist mechanism studies.
Is Retatrutide stable after reconstitution?
When reconstituted with bacteriostatic water and stored at 2-8°C, Retatrutide maintains stability for up to 28 days. Protect from light and avoid freeze-thaw cycles.
Can Retatrutide be shipped internationally?
Yes, we offer international shipping for research institutions. Retatrutide is shipped with appropriate cold chain packaging to maintain stability during transit.
